The U.S. Food and Drug Administration is weighing the need for a regulatory action on bluebird bio's gene therapy for a rare ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

Rosa DeLauro, are demanding the Food and Drug Administration ban the carcinogenic food dye FD&C Red No. 3, known as Red 3, in food. California banned Red 3 in 2023, removing it from products such ...

BridgeBio’s Attruby wins approval for transthyretin amyloid cardiomyopathy while the FDA accepts Alnylam’s application for ...

Mizuho Securities analyst Salim Syed has assigned their bullish stance on BBIO stock, giving a Buy rating on November 25.Don't Miss our Black ...

To support patients, BridgeBio will provide Attruby free for life to U.S. clinical trial participants. The company has also ...

Leerink Partners analyst Mani Foroohar has maintained their neutral stance on ALNY stock, giving a Hold rating on November 25.Don't Miss our ...

Intellia Therapeutics received the FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for nexiguran ziclumeran ...

Kronos is cutting 83% of its workforce, while Idorsia is considering cutting as many as 270 jobs. Elsewhere, PTC disclosed ...

A ceasefire between Israel and Lebanon's Hezbollah will take effect on Wednesday after both sides accepted an agreement brokered by the United States and France, U.S. President Joe Biden said on ...

Deal Could End Israel-Hezbollah Conflict That Has Lasted Over a Year Lebanon’s caretaker cabinet is expected to meet to formally approve the deal, in which it would play an essential role. Maps ...

#ex-Czech PM (Yonhap Interview) Ex-Czech PM optimistic on nuclear power plant partnership with S. Korea By Kim Seung-yeon SEOUL, Nov. 27 (Yonhap) -- A former prime minister of the Czech Republic ...